Abstract. A seroprevalence study for poliomyelitis was carried out on a sample of sera from a serum bank used for a vitamin A study. Vaccination coverage was satisfactory (80% or more) in five of nine provinces, although a prevalence of antibody to polio of 80% or more was found in all provinces. Serologic immunity (i.e., the prevalence of neutralizing antibodies) exceeded vaccination coverage, suggesting secondary spread of vaccine virus. However, whether or not water was supplied through a piped system was not associated with secondary spread of vaccine virus to nonvaccinated children. Seroprevalence studies are a valuable adjunct to acute flaccid paralysis surveillance, which is the standard surveillance instrument for the poliomyelitis eradication initiative. The use of available and suitable serum banks for seroprevalence investigations is a relatively cheap monitoring option that can yield very valuable information for the eradication initiative.
Effective surveillance is one of the four elements of the World Health Organization strategy for the global eradication of polio by the year 2000. 1, 2 In this respect, surveillance has essentially consisted of acute flaccid paralysis (AFP) surveillance, i.e., the detection and reporting of all cases of paralysis in children less than 15 years of age together with virologic examination of stool specimens from these cases (and also in certain instances their contacts) for the presence of wild-type poliovirus. The AFP surveillance has contributed significantly to the success of the eradication of polio from the Western Hemisphere in 1991 and is a key component of the maintenance of that polio-free status. 3 In South Africa, the last case of poliomyelitis due to wildtype virus was diagnosed in 1989, 4 and southern Africa has developed into one of several emerging polio-free zones in the world. 5 Formal recognition of polio-free status by the International Commission for the Certification of the Eradication of Poliomyelitis, however, requires that an adequate AFP surveillance system is in place to confirm polio-free status for at least three years and in South Africa AFP was made a statutorily notifiable disease in 1994.
While AFP has proven itself to be a highly effective instrument for monitoring the presence of circulating wild-type virus, additional information regarding the vulnerability of populations to imported poliovirus is of particular importance in countries in emerging polio-free zones that border countries where endemic infection still remains. For example, the monitoring of vaccination coverage as well as seroprevalence studies of immunity to polio could become important complementary surveillance instruments in the eradication program. Serologic studies are, however, costly exercises both for the collection of specimens as well as for the laboratory testing. Banks of sera are collected from time to time for various studies and if adequately representative samples of sera become available these should be used for seroprevalence studies. A national survey on the anthropometric, vitamin A, iron, and vaccination coverage status of children between the ages of six and 71 months was carried out in South Africa in 1995. 6 From this cohort, sera from children 12-35 months of age were selected and tested for neutralizing antibodies to polio. This data, combined with information on their vaccination history as well as demographic information, was used to assess the vulnerability of the population to imported polio from neighboring endemic countries.
SUBJECTS, MATERIALS, AND METHODS

Subjects.
The sampling methodology for the 1995 vitamin A survey has been described in detail elsewhere. 6 Briefly, a national probability sample of households was drawn with disproportionate stratification for each of the nine of South Africa. Forty clusters of approximately 52 households were selected in each province and information, including vaccination histories, was obtained from all children between six and 71 months of age in the selected households. A blood sample was taken from the first 16 children in which informed consent was obtained and the following entry criteria were complied with: the child had a temperature of less than 38ЊC and had not received high-dose vitamin A supplementation in the preceding six months. Serum samples were stored at Ϫ20ЊC and aliquots of sera from all 1,291 children who were between 12 and 35 months of age were tested for neutralizing antibodies to poliovirus. Ethical approval for the study was obtained from the Committee for Research on Human Subjects of the University of the Witwatersrand (Johannesburg, South Africa).
Vaccination history. The history of vaccination was obtained either from the child's health record or from a reliable verbal history from the mother or child-minder. The remainder were categorized as unknown vaccination history in which the mother or child-minder was not able to recall the child having received vaccine previously. These were all children who had inadequate access to health care facilities. There were no cases with a definitive history of never having received vaccine, or refusal of vaccination for any reason.
Serology. The neutralization assays were performed as previously described. [7] [8] [9] Briefly, the serum samples were inactivated at 56ЊC for 30 min before testing for polio neutralizing antibodies. Standard vaccine strains of poliovirus types 1, 2, and 3 were mixed at 100 50% tissue culture infective doses (TCID 50) /0.05 ml with an equal volume (0.05 (7) 3 (4) 14 (9) 19 (13) 29 (23) 26 (12) 4 (5) 21 (14) 15 (10) 80 (63) 173 (80) 67 (91) 117 (77) 112 (77) 6 (8) 19 (11) 14 (21) 23 (20) 19 (17 (4) 9 (9) 8 (5) 99 (8) 11 (7) 9 (6) 9 (9) 27 (18) 151 (12) 146 (89) 141 (90) 86 (83) 119 (77) 1,041 (81) 24 (16) 22 (16) 6 (7) 8 (7) 141 (14) * Values in parentheses are percentages. † One or two vaccinations. ‡ At least three primary Expanded Programs for Immunization. § Proportion of those fully vaccinated. (89) ml) of the serum sample at a constant dilution of 1:8. The mixtures were then incubated at 37oC for 1 hr in 96-well microtiter plates. To each well containing the virus-sera mixture was then added 0.1 ml of freshly trypsinized Vero cells at a concentration of 1 ϫ 10 5 /well. The plates were then incubated at 37ЊC in a 5% CO 2 incubator.
The presence of neutralizing antibodies was determined by a 50% reduction in cytopathic effect. The presence of neutralizing antibodies at a dilution of 1:8 or greater was interpreted as being indicative of immunity to that polio virus type. The majority of the sample (67%) lived in formal housing and 45% had electricity but only 36% had a refrigerator in the home. About three-quarters (74%) of the cohort were supplied with piped water.
Vaccination coverage. Vaccination coverage was satisfactory (80% or more) in five of the nine provinces, the exceptions being the Eastern Cape (63%), KwaZulu/Natal (77%), Mpumalanga (77%) and Western Cape (77%) ( Table   1 ). In the majority (79-93%, varying in different provinces) of the subjects sampled, vaccination coverage figures were obtained from history and documentation (there were no other sources of information).
Seroprevalence data. Full serologic immunity, defined by the presence of polio-neutralizing antibodies to all three polio types, was present in 89% (1,148 of 1,290) of the samples tested (Table 2) . Full immunity varied between 83% in the Eastern Cape to 96% in Gauteng. The absence of neutralizing antibodies was most evident for type 3 (from 1% to 11%) compared with 0-4% for type 1 and 0-0.9% for type 2. In four of the nine provinces the prevalence of full serologic immunity (to all 3 types) significantly exceeded the figure for full vaccination coverage (three or seven more doses of trivalent oral polio vaccine [TOPV]) (Figure 1 ). These were Eastern Cape (P ϭ 0.006, by 2 test), Free State (P ϭ 0.001, by 2 test), North West Province (P ϭ 0.017, by 2 test) and Western Cape (P ϭ 0.003, by 2 test). In the remainder the differences were not statistically significant.
The prevalence of full serologic immunity was directly related to the extent of vaccination; from 63% in those in the unknown vaccination history category to 82% in partially vaccinated children to 93% in fully vaccinated children (Table 3) . It was also observed that the level of full serologic immunity was maintained and, in fact, increased marginally from 90% to 94%, with the age of the children (Table 4) .
To investigate whether nonpiped water could play a significant role in disseminating vaccine poliovirus to unvac- cinated children and thereby increase the extent of immunity, polio seroprevalence to all three types and to type 1 specifically (since this is the only type causing paralytic polio in southern Africa) were compared with those children who had access to piped water and those who did not (Tables 5  and 6 ). No significant association between water source and the presence of antibodies to all three types, as well as to type 1 specifically, was found.
DISCUSSION
The value of AFP as an instrument for polio surveillance has been clearly demonstrated in various parts of the world. In the eradication success in the Americas as well as the subsequent certification of polio-free status, AFP surveillance has played a key role. 3 In Oman, detection of AFP cases facilitated the early diagnosis of a polio outbreak and enabled a rapid control response to be effected. 10 In Namibia, AFP cases were retrospectively revealed and went unreported in 1992-1993 less than a year before the 1993-1994 epidemics.
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For polio-free countries that have reached the desired level of AFP sensitivity (one per 100,000 children less than 15 years of age) and have also failed to detect wild-type poliovirus, it is desirable to supplement AFP surveillance with more proactive surveillance instruments that are more sensitive to detecting silent circulation of the virus. This is particularly applicable to polio, where case detection is a reflection of only one-hundredth to one-thousandth of the actual human incidence of poliovirus infection. Sewage sampling techniques have been developed but have not as yet been standardized and are still not in widespread use. 12 Random stool sampling may also be of value in detecting silent circulation of wild-type virus. 12 In this study, a sample of sera was tested that was statistically constructed to represent children 12-35 months of age from throughout South Africa. A similar nationwide seroprevalence study was carried out in South Africa in 1984 that delineated regions in the country for special attention because of low levels of immunity. 7 In the present study, the Eastern Cape province, which had an unsatisfactory level of full vaccination coverage (68%), had a significantly higher, but still inadequate, seroprevalence level of antibodies to poliovirus (83%). Nevertheless, both vaccination coverage and seroimmunity levels have improved considerably since the previous studies were carried out during epidemics and in interepidemic periods. [7] [8] [9] Antibodies to type 3 poliovirus were lower than to the other two types, as has been found in previous South African studies, 7-9 as well as elsewhere in the developing world. [13] [14] [15] This is in spite of the increase in the type 3 component of TOPV to 10 5.6 TCID 50 /dose. Subsequent to this investigation, a subnational mass immunization campaign was carried out in 1995 and national mass immunization campaigns in 1996 and 1997. The rou- The ability of oral polio vaccine to produce immunity significantly in excess of those actually immunized was demonstrated in four of the nine provinces where serologic immunity was significantly higher than vaccination coverage levels. In fact, some 63% of the sample who were either unvaccinated or where no vaccine history could be obtained (and who were probably, at best only partially vaccinated), had antibodies to all three types. Furthermore, the percentage of those children who were immune to all three types was maintained at a high level even as the age advanced beyond the vaccination schedule ages, as has also been reported in other studies, for example, in the Gambia 16 and Mexico. 17 Secondary spread of vaccine virus is clearly a feature of oral polio vaccination in developing countries, although in an inner city population in the United States, secondary spread appeared to play only a modest role in increasing immunity. 18 The route of secondary spread of vaccine virus is, however, not clear. The data from our study, which showed that the nature the of water supply did not appear to be a significant route of secondary spread of vaccine virus, would suggest that there was no association between a piped or nonpiped water supply and antibodies to all three types of poliovirus, or to type 1 specifically.
Serologic investigations have not been a feature of surveillance programs. These tests are relatively expensive and are also costly in terms of the human resources needed for the collection of specimens as well as potentially taxing the good will of health-care workers and mothers or care-givers of children. Nevertheless, when combined with data on vaccination coverage, seroprevalence studies can be especially valuable in providing important local and general information regarding population susceptibility, which is of particular relevance to countries in emerging polio-free zones that border regions that are still endemic for polio. South Africa, which has not detected wild-type polio virus since 1989, 4 is one such country which is highly vulnerable to the introduction of wild-type virus because of extensive population movements and influxes of work seekers or refugees from neighboring as well as distant countries to the north. The speed and efficiency of spread of introduced polioviruses into susceptible populations has been graphically demonstrated in several recent outbreaks, 19 including the 1993-1994 epidemic in neighboring Namibia. 20 Estimations of population susceptibility based on vaccination coverage alone may be insufficiently reliable and this may be compounded by the varying degree of vaccine efficacy seen even within different populations in the same country. 7 The prevalence of serologic immunity required for herd immunity is still unresolved. Outbreaks have occurred in the face of high vaccination coverage and serologic immunity. 9, [20] [21] [22] Serologic surveys can be used to help define regions of suboptimal immunity for special targeted programs, such as subnational mass immunization. 23 Serologic studies can also give a more precise and, in our case, a more optimistic picture (because of secondary virus spread) of herd immunity. Nevertheless, serologic studies demonstrate that immunity gaps exist despite good coverage and emphasize to sceptics 24 the necessity for mass immunization to interrupt transmission of poliovirus. 25 Serologic studies are admittedly a costly adjunct to the standard surveillance instrument such as AFP surveillance, which continues to be the cornerstone of monitoring for the eradication initiative. However, costs can be reduced if suitable serum banks of children's sera become available and are accessed, as with the vitamin A study in South Africa. The laboratory costs for the above serologic survey were $5,000. This amount could be saved, for instance, by targeted subnational mass immunization to certain delineated high risk areas in the place of national mass immunization campaigns. 23 
